SCM
HZNP
Scopia Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-473,575
| Closed | -$26.3M | – | 25 |
|
|
2020
Q2 | $26.3M | Sell |
473,575
-790,827
| -63% | -$44M | 2.9% | 13 |
|
|
2020
Q1 | $37.5M | Sell |
1,264,402
-1,263,054
| -50% | -$37.4M | 3.43% | 10 |
|
|
2019
Q4 | $91.5M | Sell |
2,527,456
-1,694,129
| -40% | -$61.3M | 7.09% | 5 |
|
|
2019
Q3 | $115M | Sell |
4,221,585
-66,902
| -2% | -$1.82M | 6.73% | 7 |
|
|
2019
Q2 | $103M | Sell |
4,288,487
-3,870,697
| -47% | -$93.1M | 4.58% | 7 |
|
|
2019
Q1 | $216M | Sell |
8,159,184
-2,566,458
| -24% | -$67.8M | 7.97% | 5 |
|
|
2018
Q4 | $210M | Sell |
10,725,642
-4,036,712
| -27% | -$78.9M | 7.11% | 5 |
|
|
2018
Q3 | $289M | Buy |
14,762,354
+2,850,064
| +24% | +$55.8M | 5.56% | 5 |
|
|
2018
Q2 | $197M | Sell |
11,912,290
-3,251,063
| -21% | -$53.8M | 3.45% | 9 |
|
|
2018
Q1 | $215M | Sell |
15,163,353
-1,207,011
| -7% | -$17.1M | 4.31% | 7 |
|
|
2017
Q4 | $239M | Buy |
16,370,364
+254,675
| +2% | +$3.72M | 4.29% | 7 |
|
|
2017
Q3 | $204M | Buy |
16,115,689
+807,546
| +5% | +$10.2M | 3.23% | 10 |
|
|
2017
Q2 | $182M | Buy |
15,308,143
+5,621,881
| +58% | +$66.7M | 3.75% | 9 |
|
|
2017
Q1 | $143M | Buy |
9,686,262
+1,604,612
| +20% | +$23.7M | 2.64% | 11 |
|
|
2016
Q4 | $131M | Buy |
+8,081,650
| New | +$131M | 2.48% | 13 |
|